Chemours Co. announced it will release its third-quarter 2026 financial results after market close on November 2, 2026. A public conference call to discuss these results will follow at 8:00 a.m. Easte
Chemours Co. will release its third-quarter 2026 financial results after market close on November 2, 2026, followed by a public webcast conference call at 8:00 a.m. EST on November 3, 2026.
Chemours reported Q2 2026 earnings with adjusted EBITDA exceeding forecasts despite lower net sales in Thermal & Specialized Solutions. The company outlined its 'Pathway to Thrive' strategy and antici
Chemours reported Q2 revenue of $1.591 billion and a $274 million GAAP loss. Analysts show mixed views, with BMO maintaining an $18.00 Buy target while UBS lowered its target to $16.00.
Chemours reported flat Q2 2026 net sales of $1.6 billion with a 128% surge in free cash flow, driven by specialty markets including data centers and semiconductors. The company highlighted improved fi
Chemours Co reported Q2 earnings of $0.42 per share and revenue of $1.59 billion, missing analyst estimates. The company's stock declined 22% in the last three months despite a 42% gain over the past
Chemours reported Q2 adjusted earnings per share of $0.42, missing analyst estimates of $0.50. The announcement highlights ongoing legal challenges, including a lawsuit by New York's Attorney General
Chemours Co declared a quarterly cash dividend of $0.0875 per share for the third quarter of 2026, payable on September 15, 2026. The global industrial and specialty chemicals leader continues its sha
Chemours Company reported Q3 2022 earnings exceeding analyst expectations, with EPS at $21.63 and revenue at $31.00 billion. This marks a 5.77% year-over-year revenue growth, accompanied by an earning
Chemours Co reported Q4 2023 earnings surpassing analyst expectations with an EPS of $0.31 and revenue of $1.36 billion, reflecting 1.72% year-over-year growth.
Chemours Co. announced it will release its second-quarter 2026 financial results after market close on August 4, followed by a public webcast conference call on August 5. Historical data indicates an
Chemours Co. expects Q2 earnings rebound with 50 cents per share forecast on $1.66 billion revenue. Investors watch margin recovery in Titanium Technologies and the impact of a $450 million EPA settle
Chemours reported 2026 Q1 earnings with an EPS of $0.05 beating estimates, though revenue of $1.38 billion missed forecasts. The earnings call presentation was published on May 7, 2026.
Chemours reported a Q1 2026 net loss of $29 million on $1.4 billion revenue, extending its 12-month net loss to $410 million. Investors remain concerned over slowing growth and margin pressures despit
Chemours Co beat Q1 2026 EPS forecasts with $0.05 per share while revenue met expectations at $1.4 billion. Shares fell 16.79% due to operational disruption concerns, though management emphasized futu
Chemours Co declared a quarterly cash dividend of $0.0875 per share for the second quarter of 2026. Payment is scheduled for June 16, 2026, to stockholders of record as of May 17, 2026.
Chemours exceeded Q1 2026 earnings expectations driven by pricing strategies in its Thermal & Specialized Solutions and Titanium Technologies segments. The company sold most Kwan Yin properties to red
Chemours Co announced its first-quarter financial results. Specific performance metrics and operational details were not detailed in the provided text.
The Chemours Company reported Q1 adjusted earnings per share of $0.05, significantly outperforming the FactSet consensus estimate of -$0.04. This positive surprise indicates stronger-than-anticipated
ChemBrief